S1PR2 and hepatocellular carcinoma: In HCC, S1P activates the Hippo pathway downstream effector YAP via S1PR2, inducing the expression of cysteine-rich protein 61 (CYR61) and connective tissue growth factor (CTGF), thereby driving abnormal tumor cell proliferation (20).